Health Impact Study of Aquatabs in Tamale, Ghana

This study has been completed.
Sponsor:
Collaborators:
Medentech Ltd.
Emory University Center for Global Safe Water
NewEnergy
University for Development Studies, Tamale, Ghana
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00252928
First received: November 10, 2005
Last updated: October 29, 2007
Last verified: October 2007

November 10, 2005
October 29, 2007
July 2006
Not Provided
Measure the impact of Aquatabs on diarrhea among persons in households in Tamale, Ghana. [ Time Frame: 12 weeks ]
Measure the impact of Aquatabs on diarrhea among persons in households in Mwanza, Tanzania.
Complete list of historical versions of study NCT00252928 on ClinicalTrials.gov Archive Site
  • Assess the microbiological quality of household water among persons living in Tamale, Ghana. [ Time Frame: 12 weeks ]
  • Determine the acceptability of Aquatabs. [ Time Frame: 12 weeks ]
  • Assess the microbiological quality of household water among persons living in Mwanza, Tanzania.
  • Determine the acceptability of Aquatabs.
Not Provided
Not Provided
 
Health Impact Study of Aquatabs in Tamale, Ghana
Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Prevention
Diarrhea
  • Other: Sodium dichloroisocyanurate (NaDCC) tablets
    Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.
    Other Name: Aquatabs
  • Other: Placebo
    Placebo
  • Placebo Comparator: A
    Placebo group does not receive Aquatabs.
    Intervention: Other: Placebo
  • Experimental: B
    Intervention arms receives Aquatabs.
    Intervention: Other: Sodium dichloroisocyanurate (NaDCC) tablets

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
240
November 2006
Not Provided

Inclusion Criteria:

  • Households with at least one child under 5 years old

Exclusion Criteria:

-

Both
Not Provided
Yes
Contact information is only displayed when the study is recruiting subjects
United States,   Ghana
 
NCT00252928
CDC-NCID-4730
Not Provided
Not Provided
Centers for Disease Control and Prevention
  • Medentech Ltd.
  • Emory University Center for Global Safe Water
  • NewEnergy
  • University for Development Studies, Tamale, Ghana
Principal Investigator: Seema Jain, MD Centers for Disease Control and Prevention
Principal Investigator: Robert Quick, MD Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP